An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

30 Pages Posted: 28 Mar 2007  

Surendra Sarnikar

University of Arizona - Eller College of Management

Ray Woosley

Critical Path Institute (C-Path)

Amar Gupta

Massachusetts Institute of Technology (MIT)

Date Written: March 5, 2007

Abstract

Adverse drug events impose a large cost on the society in terms of lives and healthcare costs. In this paper, we propose an information system for monitoring adverse drug events in an outpatient setting that can form a part of the post marketing surveillance program. The proposed system architecture builds on previous studies analyzing the involvement of community pharmacies in identifying and reporting adverse drug events. We define the key requirements of such a monitoring and reporting system, identify the critical factors that influence the successful implementation and use of the system, and propose information technology solutions that satisfy these requirements.

Keywords: Adverse event reporting, community pharmacy safety network, post-marketing surveillance

Suggested Citation

Sarnikar, Surendra and Woosley, Ray and Gupta, Amar, An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance (March 5, 2007). Available at SSRN: https://ssrn.com/abstract=968561 or http://dx.doi.org/10.2139/ssrn.968561

Surendra Sarnikar (Contact Author)

University of Arizona - Eller College of Management ( email )

McClelland Hall
P.O. Box 210108
Tucson, AZ 85721-0108
United States

Ray Woosley

Critical Path Institute (C-Path) ( email )

4280 N. Campbell Avenue
Suite 214
Tucson, AZ 85718
United States

Amar Gupta

Massachusetts Institute of Technology (MIT) ( email )

77 Massachusetts Avenue
Building 32-256
Cambridge, MA 02139
United States
617-253-0418 (Phone)

Paper statistics

Downloads
76
Rank
260,193
Abstract Views
824